Cell Therapy Potency Assay Summit
Jul 25 - Jul 27 2022
Strategies for Developing a Potency Assay for a Clonal Neoantigen-Reactive Cell Therapy Product
- Carolyn Edwards Director, Research Programs, Achilles Therapeutics
Synopsis
• Showcasing options for measuring potency effectively
• Discussing data generation in Phase I trials
• Transition from early stage to late-stage development for potency assays
• Supporting characterization and development by designing phase appropriate potency assay
